SPARTAN Group

Spondyloarthritis Research and Treatment Network

  • Become a SPARTAN Member
  • Donate
  • Contact Us
  • Log In
  • Home
  • About Us
    • About Spondyloarthritis
    • About SPARTAN
    • Corporate Supporters
    • Leadership
    • Committees
    • Awards
    • SPARTAN Newsletter Archives
    • Bylaws
  • Membership
    • Become a SPARTAN Member
    • Member Directory
  • Annual Meeting
    • 2023 SPARTAN Annual Meeting
    • 2023 Spondyloarthritis Review Course
    • 2023 Call for Trainee Abstracts
  • Projects
    • SPARTAN Projects
    • CLASSIC Study
  • Grants
    • Fellowship Grants for Pilot Projects
    • SPARTAN Overhead Policy
  • Education
    • SPARTAN GRAPPA ASAS Symposium
    • CAPES Education Series
    • GRAPPA SPARTAN Global Education Seminars
    • Case Library
    • Treatment Guidelines
  • Members
    • Password Reset
    • Log Out

2023 SPARTAN Annual Meeting Draft


2023 SPARTAN Annual Meeting

Join us in Cleveland for the 2023 Annual Meeting!

 Cleveland Marriott Downtown at Key Tower
Cleveland Marriott Downtown at Key Tower
1360 West Mall Drive Cleveland, Ohio 44114
Hotel Reservations

SPARTAN members and all Trainees will be reimbursed according to our Meeting Reimbursement Policy.

Friday, May 19, 2023—An evening at the Rock and Roll Hall of Fame

Rock and Roll Hall of Fame

Annual Meeting—Schedule of Events

Download 2023 Meeting PDF Schedule
View Spondyloarthritis Review Course Schedule

Friday, May 19

Central Daylight Time

8:00-8:10 AM Welcome
Joerg Ermann, MD, Brigham and Women’s Hospital, Boston; Chair, SPARTAN Board of Directors
8:10-8:15 AM 2023 Research Career Achievement Award Presentation
Atul Deodhar, MD, Oregon Health & Science University, Portland
8:15-9:15 AM YEAR IN REVIEW
Moderators: Vikas Majithia, MD and Sonam Kiwalkar, MD
Clinical Research
Maureen Dubreuil, MD, Boston University
Basic Science
Kristi Kuhn, MD, PhD, University of Colorado, Denver
Clinical Trials
Philip Mease, MD, Swedish Medical Center/Providence St Joseph Health, Seattle
Q & A
9:15-10:30 AM SCIENTIFIC SESSIONS
Basic Science Session
Moderators: Joerg Ermann, MD and Akihiru Nakamura, MD, PhD
CD8+ T Cells in SpA—Time to Revisit?
Robert Colbert, MD, PhD, NIH/NIAMHS
High-dimensional Single Cell Analysis in SpA
Paul Bowness, MD, University of Oxford, UK
JAK STAT Inhibitors in AxSpA
Siba Raychaudhuri, MD, University of California Davis/VA Medical Center, Sacramento
Q & A
10:30-10:50 AM BREAK
10:50-12:10 PM Clinical Session–A
Moderators: Mark Hwang, MD and Jean Liew, MD
Managing AxSpA in Pregnancy
Jessie Walsh, MD, University of Utah
Treat to Target: Tapering Strategy in AxSpA
Marina Magrey, MD, University Hospitals, Cleveland
Management of IBD Associated SpA
Jeffry Katz, MD, University Hospitals, Cleveland
Q & A
12:10-1:00 PM LUNCH
1:00-2:20 PM Clinical Session–B
Moderators: Matt Stoll, MD, PhD and Mohamad Bittar, MD, MS
How Do We Monitor Disease Activity in AxSpA in Clinical Practice?
Abhijeet Danve, MBBS, MD, FACP, Yale University, New Haven
Development of New Classification Criteria of Pediatric AxSpA
Pamela Weiss, MD, MSCE, Children’s Hospital of Philadelphia
Artificial Intelligence and Machine Learning in Diagnosis of AxSpA
Denis Poddubnyy, MD, PhD, Charité Universitätsmedizin, Berlin
Q & A
2:20-3:40 PM HLA-B27: Celebrating the 50th Anniversary
Moderators: John Reveille, MD and Runsheng Wang, MD
Broad Historical Perspective about HLA-B27
Muhamad Asim Khan, MD, PhD, Case Western Reserve University,
Cleveland (emeritus)
Potential Role of HLA-B27 in the Pathogenesis of AxSpA: What is New?
Nigel Haroon, MD, PhD, MBA, University of Toronto
Epidemiology and Clinical Significance of HLA-B27 in AxSpA
Michael Weisman, MD, Stanford Univeristy
Q & A
3:40-4:00 PM BREAK
4:00-6:00 PM RESEARCH PROJECTS
Moderator: Lianne Gensler, MD
Seed Grant Presentation
Characterizing Gut Microbial Dysbiosis in HLA-B27 Negative Axial Spondyloarthritis
Tejpal Gill, PhD, Oregon Health & Science University, Portland
Fellowship Grant Presentations
Determinants of Diagnostic Delay in Axial Spondyloarthritis Revealing Sacroiliitis in Crohn’s Disease: A Pilot Study
Gregory McDermott, MD, Brigham and Women’s Hospital, Boston
Clinical Validation of Neutrophil DTL (a Negative Regulator of IL-23) Expression in SpA
Akihiro Nakamura, MD, PhD, Queen’s University, Ontario
Oral Abstract Presentations
6:30-9:30 PM Evening at the Rock and Roll Hall of Fame

page top

Saturday, May 20

Central Daylight Time

8:00-9:00 AM Keynote Address
Moderators: Marina Magrey, MD and Elaine Husni, MD
IL-17: TH17 Cells in Autoimmunity and Autoimmune Diseases
Vijay Kuchroo, DVM, PhD, Harvard Medical School, Brigham and Women’s Hospital, Brigham Research Institutes, Boston
9:00-9:10 AM SPARTAN SESSIONS
Moderator: Joerg Ermann
SPARTAN Business
9:10-10:45 AM PROJECTS
Referral Recommendations
Maureen Dubreuil, MD, Boston University Medical Center;
Abhijeet Danve, MBBS, MD, FACP, Yale University, New Haven;
Atul Deodhar, MD, MRCP, Oregon Health & Science University, Portland
BASIS
Kristi Kuhn, MD, PhD, University of Colorado School of Medicine, Denver
Treatment Guidelines
Liron Caplan, MD, PhD, University of Colorado School of Medicine, Denver
10:45-11:00 AM BREAK
11:00-12:00 PM CLASSIC
Walter Maksymowych, MD, FRCP, FACP, University of Alberta
12:00-1:00 PM DEBATE
Moderators: Michael Ward and Liron Caplan, MD, PhD
A disparity in response to therapeutics has been observed in males and females in clinical trials—is this a biologic difference or not?
PRO: Atul Deodhar, MD MRCP, Oregon Health & Science University, Portland
CON: Lianne Gensler, MD, University of California San Francisco
1:00-1:30 PM LUNCH

Thank you to our Supporters
Thank you to our Annual Meeting sponsors

page top

About US

About SPARTAN
Leadership
Committees
ByLaws

Keep in Touch with SPARTAN

Receive the SPARTAN email newsletter, published quarterly.

Browse newsletter archives.

Twitter @spartan_updates
SPARTAN on LinkedIn

Contact Us

SPARTAN Office
PO Box 55491
Portland, OR 97238

Copyright © 2023 SPARTAN · Log in